Minutes of the Extraordinary General Meeting
16 Mar 2026 //
GLOBENEWSWIRE
Company Calls EGM for Dissolution, Delisting Proposal
23 Feb 2026 //
GLOBENEWSWIRE
PCI Biotech Halts R&D Operations, Explores Future Strategies
08 Jan 2026 //
GLOBENEWSWIRE
Minutes of Annual General Meeting 2024
24 May 2024 //
GLOBENEWSWIRE
Disclosure of voting rights for Chair of the Board
23 May 2024 //
GLOBENEWSWIRE
Minutes from Annual General Meeting 2023
25 May 2023 //
GLOBENEWSWIRE
Disclosure of voting rights for Chairman of the Board
24 May 2023 //
GLOBENEWSWIRE
Flaggemelding relatert til PCIB
20 Jan 2023 //
GLOBENEWSWIRE
PCI Biotech: Employee share option scheme
25 Nov 2022 //
GLOBENEWSWIRE
PCI Biotech interim Q3 2022 report
23 Nov 2022 //
GLOBENEWSWIRE
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
31 Aug 2022 //
ACCESSWIRE
PCI Biotech interim first-half year 2022 results
30 Aug 2022 //
GLOBENEWSWIRE
PCI Biotech: Invitation to first-half year 2022 results presentation
26 Aug 2022 //
GLOBENEWSWIRE
PCI Biotech: Company update
18 Aug 2022 //
GLOBENEWSWIRE
Minutes from Annual General Meeting 2022
25 May 2022 //
GLOBENEWSWIRE
Disclosure of voting rights for Chairman of the Board
24 May 2022 //
GLOBENEWSWIRE
PCI further expands into New England with fill-finish upgrade in New Hampshire
12 May 2022 //
ENDPTS
PCI Biotech interim first quarter 2022 results
11 May 2022 //
GLOBENEWSWIRE
PCI Biotech to present at TIDES USA 2022
09 May 2022 //
GLOBENEWSWIRE
Notice of Annual General Meeting 2022
04 May 2022 //
GLOBENEWSWIRE
PCI Biotech: Invitation to Q1 2022 results presentation
04 May 2022 //
GLOBENEWSWIRE
PCI Biotech Holding ASA publishes the Annual Report 2021
28 Apr 2022 //
GLOBENEWSWIRE
PCI Biotech: CEO resigns to assume new position
28 Mar 2022 //
GLOBENEWSWIRE
PCI Biotech fourth quarter and preliminary full year 2021 results
18 Feb 2022 //
GLOBENEWSWIRE
PCI Biotech: Update on the RELEASE trial
24 Jan 2022 //
GLOBENEWSWIRE
PCI Biotech and MDimune announce research collaboration agreement
04 Jan 2022 //
GLOBENEWSWIRE
PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration
29 Nov 2021 //
GLOBENEWSWIRE
PCI Biotech: Employee share option scheme
06 Sep 2021 //
GLOBENEWSWIRE
PCI Biotech first half-year 2021 interim results
31 Aug 2021 //
GLOBENEWSWIRE
PCI to begin awareness programmes highlighting role of CP
09 Jul 2021 //
PHARMABIZ
PCI Biotech: First US patient enrolled in the fimaChem pivotal RELEASE study
30 Apr 2021 //
GLOBENEWSWIRE
PCI Biotech: European patent for treatment of bile duct cancer with the fimaChem
16 Nov 2020 //
GLOBENEWSWIRE
PCI Biotech: Preclinical research collaboration with big pharma ended
20 Oct 2020 //
GLOBENEWSWIRE

Market Place
Sourcing Support